glp-1 medicine for weight loss drugs may be misused by patients with eating disorders: Study New GLP-1 Pill Foundayo (Orforglipron)

Adjusting Frequency During the Titration Phase Although the end goal is weekly injections, most patients begin with a lower dose and gradually increase over several weeks

Because much of the research is done in the diabetic population, its hard to get a true idea of what role medications like ozempic or saxenda have in inducing gastroparesis

Sterling JK, et al

Being poorly or incorrectly labelled

Besides the GLP-1 receptor assay, the platform includes validated assays targeting key receptors such as CCK1R , and Y2R

Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes: Interactions with Metformin